Skip to search.
 TSX Up 0.20% TSX Ventures Down 0.34%

Abbott Laboratories (ABT)

-NYSE
47.22 Down 0.15(0.32%) Mar 2, 4:00PM EST
Add to Portfolio
Prev Close:47.37
Open:47.34
Bid:46.46 x 100
Ask:47.99 x 100
1y Target Est:48.09
Beta:1.09
Earnings Date:Apr 14 - Apr 20 (Est.)
Day's Range:47.13 - 47.63
52wk Range:36.65 - 47.88
Volume:7,016,259
Avg Vol (3m):5,507,980
Market Cap:71.25B
P/E (ttm):31.71
EPS (ttm):1.49
Div & Yield:0.96 (2.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTDown 0.32%71.25B
NSRGYUp 0.01%N/A
RHHBYDown 0.42%N/A
TEVAUp 0.25%48.69B

Key Statistics

Forward P/E (1 yr):19.59
P/S (ttm):3.53
Ex-Dividend Date:13-Apr-15

Analysts

Annual EPS Est (Dec-15) :2.15
Quarterly EPS Est (Mar-15) :0.42
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):2.28

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, int... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback